Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

CAR-T cell therapy for chronic kidney disease

ABSTRACT: CAR-T cell therapy for chronic kidney disease

PROVIDER: PRJNA1212718 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR32046778_1.fastq.gz	Fastqsanger.gz
	SRR32046778_2.fastq.gz	Fastqsanger.gz
	SRR32046779_1.fastq.gz	Fastqsanger.gz
	SRR32046779_2.fastq.gz	Fastqsanger.gz
	SRR32046780_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 24

Similar Datasets

CAR-T cell therapy for chronic kidney disease

Project description:Kidney fibrosis is a hallmark of chronic kidney disease (CKD) and a potential therapeutic target. However, clinical interventions and therapies targeting kidney fibrosis remain conceptual and practical challenges due to the complex origin, functional heterogeneity and regulation of scar-forming cells. Here, we used single cell sequencing technology to identify cell-surface antigens that are broadly and specifically expressed at high levels in kidney cell types that produce extracellular matrix (ECM) during CKD, and study the therapeutic effect of CART therapy targeting the major ECM-producing cell types on kidney fibrosis, which provides a comprehensive treatment strategy for multi-organ fibrosis and its cardiovascular complications in CKD mice.

2025-01-19 | GSE287413 | GEO

gut microbiota in chronic kidney disease

Project description:gut microbiota in chronic kidney disease

| PRJEB5761 | ENA

Muscle fibrosis in chronic kidney disease

Project description:Muscle fibrosis in chronic kidney disease

| PRJNA662524 | ENA

Genetic Study of CHronic Kidney DIsease (CKD)

Project description:Genetic Study of CHronic Kidney DIsease (CKD)

| PRJNA543914 | ENA

Genetic Study of CHronic Kidney DIsease (CKD)

Project description:Genetic Study of CHronic Kidney DIsease (CKD)

| PRJNA543915 | ENA

microRNA in chronic kidney disease (CKD)

Project description:microRNA in chronic kidney disease (CKD)

2017-01-01 | GSE80247 | GEO

Methylation profiles of Chronic kidney disease

Project description:Epidemiological studies indicate that adverse intrauterine and postnatal environment has a long-lasting role in chronic kidney disease (CKD) development. Epigenetic information can represent a plausible carrier for mediating this "programming" effect. Here we demonstrate that genome-wide cytosine methylation patterns of healthy and CKD tubule samples obtained from patients show significant differences. We rarely observed differentially methylated regions (DMR) on promoters. Histone modification-based kidney specific genome-wide gene regulatory region annotation maps (promoters, enhancers, transcribed and repressed regions) were generated. DMRs mostly overlapped with putative enhancer regions and were enriched in consensus binding sequences for important renal transcription factors, indicating their importance in gene expression regulation. A core set of genes, including transforming growth factors and collagens, showed cytosine methylation changes correlating with downstream transcript levels. Our report raises the possibility that epigenetic dysregulation plays a role in CKD development via influencing core profibrotic pathways. HG18_HELP array We used custom-commercial array to detail the differences of methylation regions of human tubule epithelial cells between chronic kidney disease and normal. We sought to decrease the cell type heterogeneity of kidney tissues to increase the resolution of methylation profiles. To that end, microdissected human kidney tissue from both chronic kidney disease patient and normal are used for the HELP-assay (HpaII tiny fragment Enrichment by Ligation-mediated PCR) and hybridization on Roche NimbleGen microarrays.

2013-08-09 | E-GEOD-49557 | biostudies-arrayexpress

E-GEOD-48944

Project description:Gene expression profiles of Chronic kidney disease

2025-01-24 | E-GEOD-48944 | ExpressionAtlas

Gene expression profiles of Chronic kidney disease

Project description:Epidemiological studies indicate that adverse intrauterine and postnatal environment has a long-lasting role in chronic kidney disease (CKD) development. Epigenetic information can represent a plausible carrier for mediating this programming effect. Here we demonstrate that genome-wide cytosine methylation patterns of healthy and CKD tubule samples obtained from patients show significant differences. Cytosine methylation changes showed high concordance (98%) with a large (n=87) replication dataset. We rarely observed differentially methylated regions (DMR) on promoters. Histone modification-based kidney specific genome-wide gene regulatory region annotation maps (promoters, enhancers, transcribed and repressed regions) were generated. DMRs mostly overlapped with putative enhancer regions and were enriched in consensus binding sequences for important renal transcription factors, indicating their importance in gene expression regulation. A core set of genes, including transforming growth factors and collagens, showed cytosine methylation changes correlating with downstream transcript levels. Our report raises the possibility that epigenetic dysregulation plays a role in CKD development via influencing core profibrotic pathways. We used microarrays to detail the differences of gene expression of human tubule epithelial cells between chronic kidney disease and normal. We sought to decrease the cell type heterogeneity of kidney tissues to increase the resolution of expression profiles. To that end, microdissected human kidney tissue from both chronic kidney disease patient and normal are used for RNA extraction and hybridization on Affymetrix microarrays.

2013-07-18 | E-GEOD-48944 | biostudies-arrayexpress

Genetic Susceptibility to Chronic Kidney Disease in Nicaragua

Project description:Genetic Susceptibility to Chronic Kidney Disease in Nicaragua

| PRJNA1174283 | ENA